Pharmaceutical companies are known to maintain their profit margins even during economic downturns due to inelastic demand for their products. In this piece, I evaluated two pharma stocks, AbbVie Inc. (ABBV) and Pfizer Inc. (PFE), to determine which comes out on top. Based on the fundamental comparison of these stocks, I believe ABBV is the better buy for the reasons explained throughout this article.
Global demand and spending for medicines are expected to increase significantly in the upcoming years due to the increasing prevalence of chronic diseases, including diabetes, cancer, arthritis, and heart disease, among others, and a rapidly aging population worldwide.
